Biophytis (EPA:ALBPS)

BRIEF

published on 12/24/2024 at 07:05, 1 year 1 month ago

Biophytis to Attend 2025 JP Morgan Healthcare Conference in San Francisco

Biophytis Biotechnology Investment Opportunities JP Morgan Healthcare Conference Obesity Innovation
REGULATED PRESS RELEASE

published on 12/24/2024 at 07:00, 1 year 1 month ago

Biophytis Will Be In San Franscico During The 2025 JP Morgan Healthcare Conference
Biophytis to attend 2025 JP Morgan Healthcare Conference in San Francisco and participate in Sachs Conference and BIO@JPM Week. The company focuses on developing treatments for age-related diseases

Biophytis Biotechnology Age-related Diseases San Francisco JP Morgan Healthcare Conference
BRIEF

published on 12/23/2024 at 07:05, 1 year 1 month ago

Biophytis Presents Obesity Program at SCWD Congress

Biophytis BIO101 Obesity GLP-1 RAs Quinolia Study
REGULATED PRESS RELEASE

published on 12/23/2024 at 07:00, 1 year 1 month ago

Biophytis showcased the OBA program in obesity at the 17th SCWD international congress
Biophytis presented the OBA program in obesity at the 17th SCWD congress, showcasing positive results of BIO101 in overweight and obese patients, supporting further clinical development

Biophytis Clinical Development BIO101 Obesity OBA Program
BRIEF

published on 12/02/2024 at 07:05, 1 year 1 month ago

Biophytis Engages in SCWD Congress and Hosts Obesity Investor Call

Biophytis Investor Call Obesity Treatment GLP-1 RA SCWD Congress
REGULATED PRESS RELEASE

published on 12/02/2024 at 07:00, 1 year 1 month ago

Biophytis participates in the 17th SCWD Congress and hosts an Obesity Investor Call
Biophytis announces participation in the 17th SCWD Congress and hosting an Obesity Investor Call. Key opinion leaders to discuss GLP-1 RA therapy. Event on December 6, 2024

Biophytis Clinical Research Obesity Investor Call SCWD Congress GLP-1 RA Therapy
BRIEF

published on 09/30/2024 at 23:05, 1 year 4 months ago

Biophytis Reports First-Half Financial Results and Updates on Business Activities

Financial Results Biophytis Clinical Trials Obesity Treatment Partnerships
PRESS RELEASE

published on 09/30/2024 at 23:00, 1 year 4 months ago

Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities
Biophytis publishes first-half financial results and business activities update, including launch of obesity program and licensing agreement with Blanver for Latin America, with a focus on key achievements and financial highlights

Financial Results Biophytis Licensing Agreement Business Activities Obesity Program
REGULATED PRESS RELEASE

published on 09/30/2024 at 23:00, 1 year 4 months ago

Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities
Biophytis publishes first-half financial results and updates on business activities, highlighting key achievements including launch of OBA program for obesity with BIO101 and exclusive licensing agreement with Blanver for Latin America

Financial Results Biophytis Latin America BIO101 OBA Program
BRIEF

published on 07/22/2024 at 08:17, 1 year 6 months ago

Biophytis Enters Asia Market with Strategic Partnerships

Biophytis Pharmaceutical Partnerships Market Expansion Asia

Published on 01/31/2026 at 03:15, 5 hours 33 minutes ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 6 hours 28 minutes ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 7 hours 8 minutes ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 8 hours 48 minutes ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 9 hours 48 minutes ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 02:45, 6 hours 3 minutes ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 10 hours 48 minutes ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 12 hours 38 minutes ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 20:09, 12 hours 39 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 20:07, 12 hours 41 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches

View all EQS

Published on 01/30/2026 at 17:45, 15 hours 3 minutes ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 08:00, 1 day ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 1 day 14 hours ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 15 hours ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 15 hours ago

Cegedim generated LFL revenue growth of 1.1% in 2025

View all LES ECHOS COMFI WIRE

News